West Pharmaceutical Services Research and Development Expenses 2010-2024 | WST

West Pharmaceutical Services research and development expenses for the twelve months ending December 31, 2024 were $0.069B, a 1.02% increase year-over-year.

  • West Pharmaceutical Services annual research and development expenses for 2024 were $0.069B, a 1.02% increase from 2023.
  • West Pharmaceutical Services annual research and development expenses for 2023 were $0.068B, a 16.92% increase from 2022.
  • West Pharmaceutical Services annual research and development expenses for 2022 were $0.059B, a 10.8% increase from 2021.

West Pharmaceutical Services Research and Development Expenses 2010-2024 | WST

  • West Pharmaceutical Services annual research and development expenses for 2024 were $0.069B, a 1.02% increase from 2023.
  • West Pharmaceutical Services annual research and development expenses for 2023 were $0.068B, a 16.92% increase from 2022.
  • West Pharmaceutical Services annual research and development expenses for 2022 were $0.059B, a 10.8% increase from 2021.
Related Stocks
Company NameMarket
Cap
McKesson (MCK)$75.6B
Becton Dickinson (BDX)$65.4B
Cardinal Health (CAH)$30.8B
Straumann Holding AG (SAUHY)$23.4B
Labcorp (LH)$20.8B
Cooper (COO)$17.7B
Align Technology (ALGN)$14.8B
Henry Schein (HSIC)$9.7B
Merit Medical Systems (MMSI)$6.2B
DENTSPLY SIRONA (XRAY)$3.8B
Patterson (PDCO)$2.7B
CONMED (CNMD)$1.9B
STAAR Surgical (STAA)$830M
Lifevantage (LFVN)$211M
Pro-Dex (PDEX)$109M